Effects of matrix metalloproteinase 13 on vascular smooth muscle cells migration via Akt-ERK dependent pathway

Tissue and Cell

Volumn 47, Issue 1, 2015, Pages 115-121

  Yang, Sung Won ^a   Lim, Leejin ^a   Ju, Sujin ^a   Choi, Dong Hyun ^a   Song, Heesang ^a  

^a Chosun University   (South Korea)

Author keywords

Matrix metalloproteinase 13; Migration; PDGF; Smooth muscle cells

Indexed keywords

ANGIOTENSIN II; COLLAGENASE 3; CORDYCEPIN; GELATINASE A; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; SMALL INTERFERING RNA; DEOXYADENOSINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; AORTA; BIOSYNTHESIS; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; VASCULAR SMOOTH MUSCLE;

RATTUS;

ANGIOTENSIN II; ANIMALS; AORTA; CELL MOVEMENT; DEOXYADENOSINES; GENE EXPRESSION REGULATION; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 13; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA, MESSENGER;

EID: 84924003483     PISSN: 00408166     EISSN: 15323072     Source Type: Journal    
DOI: 10.1016/j.tice.2014.12.004     Document Type: Article

References (39)

1. Acuff H.B., Carter K.J., Fingleton B., Gorden D.L., Matrisian L.M. Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res. 2006, 66:259-266.
2. Chang W., Lim S., Song H., Song B.W., Kim H.J., Cha M.J., Sung J.M., Kim T.W., Hwang K.C. Cordycepin inhibits vascular smooth muscle cell proliferation. Eur. J. Pharmacol. 2008, 597:64-69.
3. Cheng C., Haasdijk R.A., Tempel D., den Dekker W.K., Chrifi I., Blonden L.A., van de Kamp E.H., de Boer M., Burgisser P.E., Noorderloos A., Rens J.A., Ten Hagen T.L., Duckers H.J. PDGF-induced migration of vascular smooth muscle cells is inhibited by heme oxygenase-1 via VEGFR2 upregulation and subsequent assembly of inactive VEGFR2/PDGFRbeta heterodimers. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1289-1298.
4. Chien Y.C., Sheu M.J., Wu C.H., Lin W.H., Chen Y.Y., Cheng P.L., Cheng H.C. A Chinese herbal formula "Gan-Lu-Yin" suppresses vascular smooth muscle cell migration by inhibiting matrix metalloproteinase-2/9 through the PI3K/AKT and ERK signaling pathways. BMC Complement Altern. Med. 2012, 12:137.
5. Dey N.B., Lincoln T.M. Possible involvement of cyclic-GMP-dependent protein kinase on matrix metalloproteinase-2 expression in rat aortic smooth muscle cells. Mol. Cell. Biochem. 2012, 368:27-35.
6. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28:812-819.
7. Freije J.M., Diez-Itza I., Balbin M., Sanchez L.M., Blasco R., Tolivia J., Lopez-Otin C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 1994, 269:16766-16773.
8. Gurjar M.V., Sharma R.V., Bhalla R.C. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2871-2877.
9. Halpert I., Sires U.I., Roby J.D., Potter-Perigo S., Wight T.N., Shapiro S.D., Welgus H.G., Wickline S.A., Parks W.C. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9748-9753.
10. Inada M., Wang Y., Byrne M.H., Rahman M.U., Miyaura C., Lopez-Otin C., Krane S.M. Critical roles for collagenase-3 (MMP13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17192-17197.
11. Jiang M., Bujo H., Ohwaki K., Unoki H., Yamazaki H., Kanaki T., Shibasaki M., Azuma K., Harigaya K., Schneider W.J., Saito Y. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. J. Clin. Invest. 2008, 118:2733-2746.
12. Jiang M., Bujo H., Zhu Y., Yamazaki H., Hirayama S., Kanaki T., Shibasaki M., Takahashi K., Schneider W.J., Saito Y. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells. Biochem. Biophys. Res. Commun. 2006, 348:1367-1377.
13. Johansson N., Ala-aho R., Uitto V., Grenman R., Fusenig N.E., Lopez-Otin C., Kahari V.M. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J. Cell Sci. 2000, 113(Pt 2):227-235.
14. Karki R., Jeon E.R., Kim D.W. Nelumbo nucifera leaf extract inhibits neointimal hyperplasia through modulation of smooth muscle cell proliferation and migration. Nutrition 2013, 29:268-275.
15. Knauper V., Bailey L., Worley J.R., Soloway P., Patterson M.L., Murphy G. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13. FEBS Lett. 2002, 532:127-130.
16. Knauper V., Lopez-Otin C., Smith B., Knight G., Murphy G. Biochemical characterization of human collagenase-3. J. Biol. Chem. 1996, 271:1544-1550.
17. Knauper V., Will H., Lopez-Otin C., Smith B., Atkinson S.J., Stanton H., Hembry R.M., Murphy G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J. Biol. Chem. 1996, 271:17124-17131.
18. Lizarbe T.R., Garcia-Rama C., Tarin C., Saura M., Calvo E., Lopez J.A., Lopez-Otin C., Folgueras A.R., Lamas S., Zaragoza C. Nitric oxide elicits functional MMP-13 protein-tyrosine nitration during wound repair. FASEB J. 2008, 22:3207-3215.
19. Lopez-Rivera E., Lizarbe T.R., Martinez-Moreno M., Lopez-Novoa J.M., Rodriguez-Barbero A., Rodrigo J., Fernandez A.P., Alvarez-Barrientos A., Lamas S., Zaragoza C. Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:3685-3690.
20. Mao D., Lee J.K., VanVickle S.J., Thompson R.W. Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem. Biophys. Res. Commun. 1999, 261:904-910.
21. Meierjohann S., Hufnagel A., Wende E., Kleinschmidt M.A., Wolf K., Friedl P., Gaubatz S., Schartl M. MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation. Mol. Cancer 2010, 9:201.
22. Mitchell P.G., Magna H.A., Reeves L.M., Lopresti-Morrow L.L., Yocum S.A., Rosner P.J., Geoghegan K.F., Hambor J.E. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 1996, 97:761-768.
23. Nakai K., Kawato T., Morita T., Iinuma T., Kamio N., Zhao N., Maeno M. Angiotensin II induces the production of MMP-3 and MMP-13 through the MAPK signaling pathways via the AT(1) receptor in osteoblasts. Biochimie 2013, 95:922-933.
24. Neutzner M., Lopez T., Feng X., Bergmann-Leitner E.S., Leitner W.W., Udey M.C. MFG-E8/lactadherin promotes tumor growth in an angiogenesis-dependent transgenic mouse model of multistage carcinogenesis. Cancer Res. 2007, 67:6777-6785.
25. Newby A.C. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc. Res. 2006, 69:614-624.
26. Newby A.C. Metalloproteinases and vulnerable atherosclerotic plaques. Trends Cardiovasc. Med. 2007, 17:253-258.
27. Newby A.C. Matrix metalloproteinase inhibition therapy for vascular diseases. Vasc. Pharmacol. 2012, 56:232-244.
28. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 1995, 75:487-517.
29. Pan X., Mao X., Cheng T., Zhang X. Macrophage migration inhibitory factor: a regulator of MMP13 and inflammation in titanium particles-stimulated air pouch in vivo. Mol. Cell. Biochem. 2011, 357:313-321.
30. Quillard T., Tesmenitsky Y., Croce K., Travers R., Shvartz E., Koskinas K.C., Sukhova G.K., Aikawa E., Aikawa M., Libby P. Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2464-2472.
31. Schwartz S.M., Heimark R.L., Majesky M.W. Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 1990, 70:1177-1209.
32. Sukhova G.K., Schonbeck U., Rabkin E., Schoen F.J., Poole A.R., Billinghurst R.C., Libby P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999, 99:2503-2509.
33. Tarin C., Gomez M., Calvo E., Lopez J.A., Zaragoza C. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:27-32.
34. Tuli H.S., Sharma A.K., Sandhu S.S., Kashyap D. Cordycepin: a bioactive metabolite with therapeutic potential. Life Sci. 2013, 93:863-869.
35. Xu N., Zhang L., Meisgen F., Harada M., Heilborn J., Homey B., Grander D., Stahle M., Sonkoly E., Pivarcsi A. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion. J. Biol. Chem. 2012, 287:29899-29908.
36. Ye Q., Yan Z., Liao X., Li Y., Yang J., Sun J., Kawano T., Wang X., Cao Z., Wang Z., Huang L. MUC1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13. Lab. Invest. 2011, 91:778-787.
37. Yoon S., Kuivaniemi H., Gatalica Z., Olson J.M., Buttice G., Ye S., Norris B.A., Malcom G.T., Strong J.P., Tromp G. MMP13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males. Matrix Biol. 2002, 21:487-498.
38. Yu T., Wu Y., Helman J.I., Wen Y., Wang C., Li L. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Mol. Cancer Res. 2011, 9:161-172.
39. Zigrino P., Kuhn I., Bauerle T., Zamek J., Fox J.W., Neumann S., Licht A., Schorpp-Kistner M., Angel P., Mauch C. Stromal expression of MMP-13 is required for melanoma invasion and metastasis. J. Invest. Dermatol. 2009, 129:2686-2693.